These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 25640943)

  • 61. Elevated PLGF contributes to small-cell lung cancer brain metastasis.
    Li B; Wang C; Zhang Y; Zhao XY; Huang B; Wu PF; Li Q; Li H; Liu YS; Cao LY; Dai WM; Fang WG; Shang DS; Cao L; Zhao WD; Chen YH
    Oncogene; 2013 Jun; 32(24):2952-62. PubMed ID: 22797069
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CXCR4 antagonists suppress small cell lung cancer progression.
    Taromi S; Kayser G; Catusse J; von Elverfeldt D; Reichardt W; Braun F; Weber WA; Zeiser R; Burger M
    Oncotarget; 2016 Dec; 7(51):85185-85195. PubMed ID: 27835905
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2.
    Liu T; Miao Z; Jiang J; Yuan S; Fang W; Li B; Chen Y
    Int J Mol Sci; 2015 May; 16(5):11439-51. PubMed ID: 25993304
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MET signaling: novel targeted inhibition and its clinical development in lung cancer.
    Feng Y; Thiagarajan PS; Ma PC
    J Thorac Oncol; 2012 Feb; 7(2):459-67. PubMed ID: 22237263
    [TBL] [Abstract][Full Text] [Related]  

  • 65. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.
    D'Amico L; Belisario D; Migliardi G; Grange C; Bussolati B; D'Amelio P; Perera T; Dalmasso E; Dalle Carbonare L; Godio L; Comoglio P; Trusolino L; Ferracini R; Roato I
    Oncotarget; 2016 Jul; 7(29):45525-45537. PubMed ID: 27322553
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.
    Meder L; Orschel CI; Otto CJ; Koker M; Brägelmann J; Ercanoglu MS; Dähling S; Compes A; Selenz C; Nill M; Dietlein F; Florin A; Eich ML; Borchmann S; Odenthal M; Blazquez R; Hilberg F; Klein F; Hallek M; Büttner R; Reinhardt HC; Ullrich RT
    JCI Insight; 2024 May; 9(10):. PubMed ID: 38775153
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain.
    Xu ZH; Miao ZW; Jiang QZ; Gan DX; Wei XG; Xue XZ; Li JQ; Zheng F; Qin XX; Fang WG; Chen YH; Li B
    FASEB J; 2019 Feb; 33(2):1742-1757. PubMed ID: 30183374
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of the intravascular microenvironment in spontaneous metastasis development.
    Zhang Q; Yang M; Shen J; Gerhold LM; Hoffman RM; Xing HR
    Int J Cancer; 2010 Jun; 126(11):2534-41. PubMed ID: 19847811
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis.
    Kwon MC; Proost N; Song JY; Sutherland KD; Zevenhoven J; Berns A
    Genes Dev; 2015 Aug; 29(15):1587-92. PubMed ID: 26215568
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis.
    Shen W; Pang H; Xin B; Duan L; Liu L; Zhang H
    Int J Oncol; 2018 Sep; 53(3):1354-1362. PubMed ID: 30015928
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis.
    Liu Y; Liu YS; Wu PF; Li Q; Dai WM; Yuan S; Xu ZH; Liu TT; Miao ZW; Fang WG; Chen YH; Li B
    Int J Biochem Cell Biol; 2015 Sep; 66():11-9. PubMed ID: 26135980
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection.
    An Z; Jiang P; Wang X; Moossa AR; Hoffman RM
    Clin Exp Metastasis; 1999 May; 17(3):265-70. PubMed ID: 10432012
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].
    Li Y; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):625-34. PubMed ID: 25130970
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A noteworthy treatment of metastatic small-cell lung cancer with afatinib, followed by subsequent development of rare metastatic lesions in the ascending and sigmoid colon.
    Hsiao SC; Chen YH; Lo CC; Lin CI
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1243. PubMed ID: 32671978
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multiple Blockades of the HGF/Met Signaling Pathway for Metastasis Suppression Using Nanoinhibitors.
    Shi T; Hu J; Wang W; Jiang Q; Xu Z; Yu S; Wang F; Liu X
    ACS Appl Mater Interfaces; 2021 Jul; 13(26):30350-30358. PubMed ID: 34165951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Isolation and characterization of human lung cancer cell subline with different metastatic potential].
    Zhu W; Zheng J; Fang W
    Zhonghua Bing Li Xue Za Zhi; 1995 Jun; 24(3):136-8. PubMed ID: 7656376
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Biological Effects of Dickkopf1 on Small Cell Lung Cancer Cells and Bone Metastasis.
    Pang H; Ma N; Jiao M; Shen W; Xin B; Wang T; Zhang F; Liu L; Zhang H
    Oncol Res; 2017 Jan; 25(1):35-42. PubMed ID: 28081731
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
    Sadiq AA; Geynisman DM; Salgia R
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1810-1. PubMed ID: 22005540
    [No Abstract]   [Full Text] [Related]  

  • 79. Cancer Cell Derived Small Extracellular Vesicles Contribute to Recipient Cell Metastasis Through Promoting HGF/c-Met Pathway.
    Qiao Z; Zhang Y; Ge M; Liu S; Jiang X; Shang Z; Liu H; Cao C; Xiao H
    Mol Cell Proteomics; 2019 Aug; 18(8):1619-1629. PubMed ID: 31196968
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model.
    Liu J; Costello PC; Pham NA; Pintillie M; Jabali M; Sanghera J; Tsao MS; Johnston MR
    J Thorac Oncol; 2006 Oct; 1(8):771-9. PubMed ID: 17409959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.